PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Neurosciences (M.G., J.M.O., A.G., M.M.), University of Calgary, Canada.\', \'Department of Radiology (M.G.), University of Calgary, Canada.\', \'Department of Neuroradiology, University Hospital Basel, Switzerland (J.M.O.).\', \'Department of Neurology, Medical University of Vienna, Austria (M.M.).\', \'Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (M.F.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/STROKEAHA.120.031976
?:hasPublicationType
?:journal
  • Stroke
is ?:pmid of
?:pmid
?:pmid
  • 33588599
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.529
?:rankingScore_hIndex
  • 285
?:title
  • Rethinking Consent for Stroke Trials in Time-Sensitive Situations: Insights From the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all